 |
English
|
正體中文
|
简体中文
|
全文筆數/總筆數 : 12500/13673 (91%)
造訪人次 : 2478451
線上人數 : 87
|
|
|
資料載入中.....
|
請使用永久網址來引用或連結此文件:
http://ir.nhri.org.tw/handle/3990099045/11216
|
題名: | Intrahepatic hepatitis B virus large surface antigen induces hepatocyte hyperploidy via failure of cytokinesis |
作者: | Li, TN;Wu, YJ;Tsai, HW;Sun, CP;Wu, YH;Wu, HL;Pei, YN;Lu, KY;Yen, TT;Chang, CW;Chan, HL;Tao, MH;Liou, JY;Chang, MD;Su, IJ;Wang, LH |
貢獻者: | Institute of Cellular and Systems Medicine |
摘要: | Hepatitis B virus (HBV) is an etiological factor of liver cirrhosis and hepatocellular carcinoma (HCC). Despite current antiviral therapies that successfully reduce viral load in patients with chronic hepatitis B, persistent viral surface antigen (HBsAg) remains a risk factor of HCC. To explore if intrahepatic viral antigens contribute directly to hepatocarcinogenesis, we monitored mitotic progression of HBV-positive cells. Cytokinesis failure was increased in HBV-positive HepG2.2.15 and 1.3ES2 cells, as well as HuH-7 cells transfected with wild type or X-deficient HBV construct, but not cells transfected with an HBsAg-deficient construct. We show that expression of viral large surface antigen (LHBS) was sufficient to induce cytokinesis failure of immortalized hepatocytes. Pre-mitotic defects with DNA damage and G2/M checkpoint attenuation preceded cytokinesis in LHBS-expressing cells, and ultimately resulted in hyperploidy. Inhibition of polo-like kinase-1 (Plk1) not only restored the G2/M checkpoint in these cells, but also suppressed LHBS-mediated in vivo tumorigenesis. Finally, a positive correlation between intrahepatic LHBS expression and hepatocyte hyperploidy was detected in more than 70% of patients with chronic hepatitis B. We conclude that HBV LHBS provokes hyperploidy through inducing DNA damage and the upregulation of Plk1; the former causes atypical chromatin structures and the latter attenuates function of the G2/M DNA damage checkpoint. Our data uncover a mechanism whereby mitotic cytokinesis can be regulated by viral LHBS, warranting intrahepatic LHBS as an oncogenic caveat for the development of HCC in patients with chronic hepatitis B. |
日期: | 2018-08 |
關聯: | Journal of Pathology. 2018 Aug;245(5):502-513. |
Link to: | http://dx.doi.org/10.1002/path.5102 |
JIF/Ranking 2023: | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=0022-3417&DestApp=IC2JCR |
Cited Times(WOS): | https://www.webofscience.com/wos/woscc/full-record/WOS:000438654600011 |
Cited Times(Scopus): | https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85049943324 |
顯示於類別: | [劉俊揚] 期刊論文
|
文件中的檔案:
檔案 |
描述 |
大小 | 格式 | 瀏覽次數 |
PUB29862509.pdf | | 1727Kb | Adobe PDF | 334 | 檢視/開啟 |
|
在NHRI中所有的資料項目都受到原著作權保護.
|